B Braun Medical Outlook IV Set Recall 162,648 Units for Backflow Risk (2025)
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
1,320 recalls tagged with “fda regulated”.
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
Medline Industries recalled 11,291,800 units of Quick Strip Fabric Sterile Adhesive Bandages on October 27, 2025. The recall affects all lots due to potential open seals that compromise sterility. Consumers should stop using these bandages immediately.
Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.
Product may be contaminated with E. coli O7:K1 (IAI39/ExPEC) and E. coli 1303
EDAN recalled 3,824 Patient Monitors on October 24, 2025. The recall follows an FDA letter regarding cybersecurity vulnerabilities. Affected models include X8, X10, and X12, distributed nationwide and to Mexico.
As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
Failed stability specifications: Out of specification for hardness test
GE Medical Systems recalled 1,818 Senographe Pristina mammography systems on October 24, 2025. The recall affects systems due to missing or incorrect X-Ray Warning labels. This nonconformance to FDA regulations poses a high hazard risk.
Potential contamination of Salmonella Richmond


Lack of Assurance of Sterility.